BioSpace News Archive

Aziyo Biologics, Inc., a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced that it will release second quarter 2022 financial results after market close on Thursday, August 11, 2022.

Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, announced plans to present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California.

Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, announced that it will report financial results for the second quarter 2022 after the market close on Tuesday, August 9, 2022.

Ultragenyx Pharmaceutical Inc. reported its financial results for the quarter ended June 30, 2022 and provided a corporate update for the year.

Eagle Pharmaceuticals, Inc. announced that the Company will release its 2022 second quarter financial results on Tuesday, August 9, 2022, before the market opens.

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced that the Company will release its second quarter 2022 financial results on Thursday, August 4, 2022, after the close of U.S. markets.

Zynex, Inc. an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, reported financial results for the second quarter ended June 30, 2022.

Fortive Reports Strong Second Quarter 2022 Results; Raises Full Year 2022 Outlook

Caladrius Biosciences, Inc. today announced that the Company will report its financial results for the three and six months ended June 30, 2022, on Thursday, August 4, 2022, at 4:30 p.m. (EDT).

Vallon Pharmaceuticals, Inc. today reported its financial results for the quarter ended June 30, 2022 and provided a corporate update.